##semicolon##
тромбин, фибринолиз, ИБС##submission.citations##
Зокирова М.Б. Нуриллаева Н.М. «Клинико–диагностическое значение эндогенных факторов фибринолиза у больных c ишемической болезнью сердца»: автореф. дис.. канд. мед. наук: 14.00.06 – Кардиология; 2024.
Auwerx J, Bouillon R, Collen D, Geboers J. Tissue–type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Artherosclerosis. 1988; 8:68–72
Stegenga ME, Crabben SN van der, Levi M, de Vos AF, Tanck MW, Sauerwein HP, Poll T van der. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006; 8(6):1807–12. doi: 10.2337/db05–1543
Jax TW, Peters AJ, Plehn G, Schoebel FC. Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol. 2009; 8:24. doi: 10.1186/ 1475–2840–8–24.
Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1) N Engl J Med. 1992; 8(4):242–50. doi: 10.1056/NEJM1992012332 60406.
John W. G. Yarnell, Peter M. Sweetnam,Ann Rumley and Gordon D. O. Lowe Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease The Caerphilly Study arteriosclerosis, Thrombosis, and Vascular Biology. 2000 | Volume 20, Issue 1:271–279, originally published January 1, 2000, https:// doi.org/10.1161/01.ATV.20.1.271
Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity and white cell count are major risk factors for ischemic heart disease. Circulation. 1991; 83: 836–844
Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta–analysis and review of the literature. Ann Intern Med. 1993; 118:963–965. Google Scholar
Yarnell JWG, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O’Brien JR, Etherington NW. Some long term effects of smoking on the hemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol.1987; 40:909–913